Skip to main content
Kenneth Cooke, MD, Pediatric Hematology & Oncology, Baltimore, MD

Kenneth Robert Cooke MD


Professor of Oncology, Johns Hopkins University School of Medicine; Director, The Sidney Kimmel Comprehensive Cancer Center''s Division of Pediatic Oncology, Blood and Marrow Transplant Program

Join to View Full Profile
  • 1800 Orleans StreetBloomberg 11NBaltimore, MD 21287

  • Phone+1 410-955-8751

  • Fax+1 410-614-1802

Dr. Cooke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1993 - 1996
  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaResidency, Pediatrics, 1990 - 1993
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 1990

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2013 - 2026
  • OH State Medical License
    OH State Medical License 2008 - 2015
  • MI State Medical License
    MI State Medical License 1999 - 2009
  • PA State Medical License
    PA State Medical License 1992 - 1994

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Elected Member The American Society for Clinical Investigation, 2008

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • The Path to Cure: Using Haploidentical (haplo) Donors and High-Dose Post-Transplant Cyclophosphamide (PTCy) for Treatment-Na¥ve and Refractory Severe Aplastic Anemia (...
    Kenneth R. Cooke, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Johns Hopkins Brings Innovative Blood Stem Cell Transplant Treatments to Patients
    Johns Hopkins Brings Innovative Blood Stem Cell Transplant Treatments to PatientsJuly 31st, 2024
  • Fresh Strategies Aimed at Taming GVHD
    Fresh Strategies Aimed at Taming GVHDSeptember 20th, 2016
  • Multi-Institutional Prospective Research of Expanded Multi-Antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies (RESOLVE)
    Multi-Institutional Prospective Research of Expanded Multi-Antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies (RESOLVE)July 30th, 2014

Grant Support

  • Inflammatory mechanisms responsible for the development of multiple organ dysfunction in pediatric patients following allogeneic blood and marrow transplantation (BMT).JOHNS HOPKINS UNIVERSITY2020–2026
  • Cytokine Modulation Strategies In Clinical Allogeneic BMTNational Cancer Institute2007–2008
  • Mechanisms Of Leukocyte Recruitment During IPS After BMTNational Heart, Lung, And Blood Institute2007
  • Cytokine Modulation Strategy In Clinical Allogeneic BMTNational Cancer Institute2004–2006
  • Mechanisms Of Leukocyte Recruitment During IPS After BMTNational Heart, Lung, And Blood Institute2003–2006
  • Pathophysiologic Mechanisms Of Lung Injury After BMTNational Heart, Lung, And Blood Institute1999–2000
  • Pathophysiologic Mechanisms Of Lung Injury After BMTNational Heart, Lung, And Blood Institute1996–1998

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: